However, in mammals, p53 activity also declines with age, and this decrease has been proposed to be a contributing factor to the increased tumor incidence in older populations [41], as well as being linked to cellular senescence [47], and antagonistic pleiotropy in aging [48]. The gene discussed is TP53; the disease is neoplasm.